April 28, 2020 / 12:39 PM / a month ago

BRIEF-Catalyst Biosciences Receives Patent in the European Union for Its Factor IX Portfolio

April 28 (Reuters) - Catalyst Biosciences Inc:

* EUROPEAN PATENT OFFICE ISSUED CO A FIX PORTFOLIO PATENT COVERING LEAD CLINICAL CANDIDATE FOR FACTOR IX (FIX) REPLACEMENT THERAPY, CO’S FIX PRECLINICAL GENE THERAPY CANDIDATE CB 2679D-GT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below